Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oculis

19.57
-0.0700-0.36%
Post-market: 19.570.00000.00%17:52 EDT
Volume:51.97K
Turnover:1.02M
Market Cap:918.71M
PE:-8.35
High:19.84
Open:19.20
Low:19.20
Close:19.64
Loading ...

Oculis Holding Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
08 Nov 2024

Oculis Holding Q3 2024 Adj. EPS CHF(0.48) Beats CHF(0.49) Estimate, Cash Balance Of CHF105.5M

Benzinga
·
07 Nov 2024

Press Release: Oculis Reports Q3 2024 Financial Results and Provides Company Updates

Dow Jones
·
07 Nov 2024

Coherent Corp. Reports First Quarter Fiscal 2025 Results

GlobeNewswire
·
07 Nov 2024

1 Top Growth Stock Down 50% to Buy After Its Recent Pullback

Motley Fool
·
04 Nov 2024

Oculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39%

Simply Wall St.
·
30 Oct 2024

Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries

Benzinga
·
30 Oct 2024

Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?

Zacks
·
29 Oct 2024

TransMedics Misses on Earnings, Revenue

Motley Fool
·
29 Oct 2024

Oculis Holding Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Oct 2024

Oculis Holding Gains ‘Buy’ Rating Amid Promising Clinical Trial Advancements and Pipeline Potential

TIPRANKS
·
23 Oct 2024

Oculis Holding AG's (NASDAQ:OCS) market cap touched US$586m last week, benefiting both individual investors who own 55% as well as institutions

Simply Wall St.
·
22 Oct 2024

Oculis Up Over 11%, on Pace for Record High Close -- Data Talk

Dow Jones
·
21 Oct 2024

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

GlobeNewswire
·
21 Oct 2024

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

GlobeNewswire
·
15 Oct 2024

2 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Motley Fool
·
10 Oct 2024